Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-03-08
2005-03-08
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S934000, C514S894000, C536S028510, C536S028500, C536S055300
Reexamination Certificate
active
06864244
ABSTRACT:
The present invention relates to the hemisulfate salt of 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxymethyl)-1(R)-cyclopentyl]cytosine (Ia) with improved stability and physical properties which facilitate manufacturing, handling and formulating I and polymorphic crystalline forms thereof.
REFERENCES:
patent: 5449664 (1995-09-01), Verheyden et al.
patent: WO 0218404 (2002-03-01), None
patent: WO 02100415 (2002-12-01), None
Moffatt, J.G., “Chemical Transformations of the Sugar Moiety of Nucleosides”, Nucleoside Analogues, (R. T. Walker, E. De Clercq, & F. Eckstein, eds.), (1979), pp. 71-164, Plenum Press, New York. (see p. 144).
Maag, Hans, et al., “Synthesis and Anti-HIV Activity of 4′-Azido- and 4′- Methoxynucleosides,”J. Med. Chem., 1992, pp. 1440-1451, 35(8), (Table I).
Connolly Terrence Joseph
Martin Joseph Armstrong
Prince Anthony
Sarma Keshab
Buckwalter Brian L.
Henry Michael C.
Roche Palo Alto LLC
Wilson James O.
LandOfFree
Anhydrous crystalline... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anhydrous crystalline..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anhydrous crystalline... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3401889